+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 25Weeks - 34Weeks
All Genders
ID07896070

Evaluating Higher Versus Standard Zinc Supplementation to Improve Growth in Extremely Premature Infants

Led by Augusta University · Updated on 2026-10-26

30

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate whether higher doses of zinc supplementation within safe limits can improve growth in preterm infants. The study focuses on comparing weight gain in babies born extremely prematurely or with extremely low birth weight. It assesses important health outcomes including head circumference, length growth, and lung condition known as bronchopulmonary dysplasia. Participants will receive either a lower dose of zinc 1 mgkg per day or a higher dose 3 mgkg per day given enterally according to the neonatal intensive care unit feeding protocol. The zinc supplementation will start based on standard feeding guidelines and continue until usual care indicates stopping, around 33 to 35 weeks post-menstrual age. During the study, infants will be closely monitored from birth until 36 weeks post-menstrual age or discharge from the NICU. Researchers will measure weight velocity as the main outcome, along with head circumference, length velocity, lung health at 36 weeks, and hospital stay length. Possible risks include gastrointestinal intolerance and anemia. The total participation period aligns with their stay in the NICU until the study endpoints are reached.

CONDITIONS

Brief Title

Impact of Higher Zinc Supplementation on Neonatal Weight Velocity

Research Team

J

Julia Newman, DO

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here